The Company is a Korea-based company mainly engaged in the and research, development and manufacture of plant cell derived active substances and plant cell derived pharmacological substances. The Company is mainly engaged in the manufacture and sale of soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, acanthopanax koreanum adventitious root culture extract. The Company s products are mainly used as materials for cosmeceuticals, health functional foods and pharmaceuticals. The Company was established on November 11, 2005. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on February 21, 2022.
Headquarters
A-509~512,30,Songdommirae-Ro, Yeonsu-Gu
Incheon; Incheon;
Contact Details: Purchase the Bio-Fd&C Co.,Ltd. report to view the information.
Website: http://www.biofdnc.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service